# Circadian Thermal Sensing to Detect Breast Disease

> **NCT02511301** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Cyrcadia Health** · enrollment: 173 (estimated)

## Conditions studied

- Early-Stage Breast Carcinoma

## Interventions

- **DEVICE:** Cyrcadia CBR™ device placement for abnormality screening

## Key facts

- **NCT ID:** NCT02511301
- **Lead sponsor:** Cyrcadia Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2020-02
- **Final completion:** 2020-02
- **Target enrollment:** 173 (ESTIMATED)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02511301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02511301, "Circadian Thermal Sensing to Detect Breast Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02511301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*